KYTX
Kyverna Therapeutics Inc.
$8.78
+$0.42(+5.02%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$299.26M
Volume
1.10M
52W Range
$1.78 - $9.75
Target Price
$25.25
EPS Estimates Overview
| Current Quarter | $-0.84 | Next Quarter | $-0.9 |
| Current Year | $-3.7 | Next Year | $-3.63 |
| QoQ Growth | -7.1% | YoY Growth | +1.9% |
| 3Y EPS CAGR | +77.1% | Target Price | $25.25 |
| Consensus | Buy | Upside | +187.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $8.78 | +5.0% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW